跳至主要内容
临床试验/NCT01343290
NCT01343290已完成1 期

A Single-Dose, Open-Label, Randomized, 2-Period, 2-Sequence, Crossover Study to Determine the Effect of Food Coadministration on the Pharmacokinetics of 300 mg Canagliflozin in Healthy Subjects

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.0 个研究点目标入组 24 人开始时间: 2011年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
24
主要终点
Concentration of canagliflozin in plasma samples

研究概览

简要总结

The purpose of this study is to assess the effect of food on the absorption of canagliflozin in the body when canagliflozin is taken with and without food by healthy volunteers

详细描述

This is a single-center, single-dose, open-label (volunteers will know the identity of assigned treatment), randomized (one of 2 study drug sequences assigned by chance) study to evaluate the oral bioavailability (the degree to which the drug is absorbed in the body when taken orally by mouth) of canagliflozin when taken with and without food in healthy volunteers. Healthy Volunteers will take 1 canagliflozin tablet orally for 1 day in 2 treatment periods (canagliflozin will be taken with food in 1 treatment period and canagliflozin will be taken without food in 1 treatment period); the 2 treatment periods will be separated by a 10- to 14-day washout period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteers with a body mass index between 18 and 30 kg/m2 (inclusive) and body weight not less than 50 kg

排除标准

  • of or current medical illness deemed clinically significant by the Investigator (study physician)

研究组 & 干预措施

001

Experimental

Canagliflozin Type = 1 unit = mg number = 300 form = tablet route = oral use. Single tablet taken with or without a meal during 2 treatment periods

干预措施: Canagliflozin (Drug)

结局指标

主要结局

Concentration of canagliflozin in plasma samples

时间窗: For up to 8 days

次要结局

  • Adverse events reported(Up to approximately 34 days)
  • Vital signs measurements(Up to approximately 34 days)
  • Results from clinical chemistries performed(Up to approximately 34 days)
  • Results from 12-lead ECGs performed(Up to approximately 34 days)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验